Free National NPI Number Registry
Dr. Farhad Ardeshirpour
Home >Dr. Farhad Ardeshirpour
NPI Number Detailed Information
Provider Information:
Name: | Dr. Farhad Ardeshirpour |
Gender: | M |
Provider License Number If Given: | A132714 |
NPI Information:
NPI: | 1932376514 |
Entity Type (Individual or Organization): |
1-ind |
Enumeration Date: | 5/13/2008 |
Last Update Date: | 4/19/2023 |
Reputation Report: |
Provider Business Mailing Address:
Address: | 6 BORMES Irvine, CA 92614 |
Phone Number: | 9192448938 |
Fax Number: |
Provider Business Practice Location Address:
Address: | 150 S RODEO DR STE 260 Beverly Hills, CA 90212 |
Phone Number: | 4242428608 |
Fax Number: | 4242420410 |
Provider Taxonomy:
Primary: | 204E00000X |
Secondary (if any): | 207N00000X |
State: | CA |
Top Doctors in CA
About Dr. Farhad Ardeshirpour
Dr. Farhad Ardeshirpour (DR. FARHAD ARDESHIRPOUR ) is Oral Oral & Maxillofacial Surgery Physician in Beverly Hills, CA.
The NPI Number for Dr. Farhad Ardeshirpour is 1932376514.
The current location address for Dr. Farhad Ardeshirpour is 150 S RODEO DR STE 260 Beverly Hills, CA 90212 and the contact number is 9192448938 and fax number is .
The mailing address for Dr. Farhad Ardeshirpour is 6 BORMES Irvine, CA 92614- 4242428608 (mailing address contact number - 9192448938).
Oral and maxillofacial surgeons are trained to recognize and treat a wide spectrum of diseases, injuries and defects in the head, neck, face, jaws and the hard and soft tissues of the oral and maxillofacial region. They are also trained to administer anesthesia, and provide care in an office setting. They are trained to treat problems such as the extraction of wisdom teeth, misaligned jaws, tumors and cysts of the jaw and mouth, and to perform dental implant surgery.
Provider Business Location on Map
FAQs:
What is the NPI Number for Dr. Farhad Ardeshirpour ?
Answer: The NPI Number for Dr. Farhad Ardeshirpour is 1932376514
Where is Dr. Farhad Ardeshirpour located?
Answer: Dr. Farhad Ardeshirpour is located at 150 S RODEO DR STE 260 Beverly Hills, CA 90212.
What is the specialty for Dr. Farhad Ardeshirpour ?
Answer: The Specialty of Dr. Farhad Ardeshirpour is Oral Oral & Maxillofacial Surgery Physician.
Are there any online reviews for Dr. Farhad Ardeshirpour ?
Answer: Yes! Check It Now.
Are there any other health care providers in Beverly Hills, CA?
Answer: Yes, there are given below...
Medicare Physician & Other Practitioners
Information on services and procedures provided to Original Medicare (fee-for-service) Part B (Medical Insurance) beneficiaries by Dr. Farhad Ardeshirpour
Medicare Part D Prescribers
Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.
Provider Specialty Type | Plastic and Reconstructive Surgery |
Source of Provider Specialty | |
Number of Medicare Part D Claims, Including Refills | 146 |
Number of Standardized 30-Day Fills | 148 |
Aggregate Cost Paid for All Claims | 1460 |
Number of Day's Supply for All Claims | 1759 |
Number of Medicare Beneficiaries | 90 |
Number of Claims, Including Refills, for Beneficiaries Age 65+ | 146 |
Including Refills, for Beneficiaries Age 65+ | 148 |
Beneficiaries Age 65+ | 1460 |
Number of Day's Supply for All Claims for Beneficaries Age 65+ | 1759 |
Number of Medicare Beneficiaries Age 65+ | 90 |
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst | * |
Total Claims of Brand-Name Drugs | |
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst | |
Total Claims of Generic Drugs, Including Refills | 145 |
Aggregate Cost Paid for Generic Drugs | 1450.61 |
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst | # |
Total Claims of Other Drugs, Including Refills | |
Aggregate Cost Paid for Other Drugs | |
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst | * |
Number of Claims for Beneficiaries Covered by MAPD Plans | |
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans | |
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst | # |
Number of Claims for Beneficiaries Covered by Standalone PDP Plans | |
Aggregate Cost Paid for Claims Filled by | |
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst | * |
Number of Claims for Beneficiaries Covered by Low-Income Subsidy | |
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy | |
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst | # |
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy | |
by Low-Income Subsidy | |
Total Claims of Opioid Drugs, Including | |
Aggregate Cost Paid for Opioid Drugs | |
Opioid Claims | |
Opioid_Tot_Clms divided by the Tot_Clms | |
Total Claims of Long-Acting Opioid Drugs | |
Aggregate Cost Paid for Long-Acting Opioid | |
Number of Day's Supply of All Long-Acting | |
Long-Acting Opioid Claims | |
Opioid_LA_Tot_Clms divided by the | |
Total Claims of Antibiotic Drugs, Including | 104 |
Aggregate Cost Paid for Antibiotic Drugs | 1193.34 |
Antibiotic Claims | 84 |
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst | |
Including Refills, for Beneficiaries Age 65+ | 0 |
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+ | 0 |
Reason for Suppression of Antpsyct_GE65_Tot_Benes | |
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims | 0 |
Average Age of Beneficiaries | 79.122222222 |
Number of Beneficiaries Age Less Than 65 | 0 |
Number of Beneficiaries Age 65 to 74 | 27 |
Number of Beneficiaries Age 75 to 84 | 40 |
Number of Female Beneficiaries | 30 |
Number of Male Beneficiaries | 60 |
Number of Non-Hispanic White | 81 |
Number of Black or African American | |
Number of Asian Pacific Islander | 0 |
Number of Hispanic Beneficiaries | |
Number of American Indian/Alaskan NativeBeneficiaries | 0 |
Number of Beneficiaries with Race Not | |
Only Entitlement | |
Average Hierarchical Condition Category | 1.0523083664 |
More Providers in beverly-hills , ca
Dr. farhad ardeshirpour in Other Directories
Provider don't have other directory link yet.